Month: March 2021

VANCOUVER, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that it has completed an eight-week controlled testing period for a Cosolvent Injection System (“CIS”) add-on developed by Vitalis Extraction Technology, Inc. (“Vitalis”) for its CO2 extraction machinery. This installation of the Vitalis CIS is the first of its kind in the cannabis industry. The Vitalis CIS add-on is designed to enhance the extraction process for cannabis and hemp by using an ethanol-powered mechanism to significantly reduce runtime and operational costs as well as to improve winterization, both of which are important considerations in the Company’s extraction operations. A photo accompanying this announcement...

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act This stock exchange notice follows previous references made in the Norwegian stock exchange notices issued on June 24th 2019 regarding the Letter of Intent with Garden of Life® and the last quarterly report from HBC, which was published on February 5th 2021. European Biotech and consumer health company HBC has received the first Salmon Protein purchase orders from US-based organic health supplement firm Garden of Life. The Nestle owned company intends to launch new ProGo® consumer protein products which will be available online and for the North American markets in Q3 2021. ProGo® is an all-natural, non-GMO and additive-free salmon protein hydrolysate. It is also the first and only non-iron containing product in the...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND PROVINCES, EVERY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, NEW ZEALAND, JAPAN, CANADA, HONG KONG OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.   SAINT HELIER, Jersey, Mar 31, 2021 | CoinShares International Limited, (Nasdaq First North Growth Market: CS) (“CoinShares” or the “Group” or the “Company”) today announced preliminary financial results and operational update for the fourth quarter and the year-ended 31 December 2020. The full report, which is attached to this...

Press Release 31 March 2021 NOTICE OF ANNUAL GENERAL MEETING IN IMMUNICUM AB (PUBL) The shareholders of Immunicum AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Annual General Meeting (“AGM”) on Tuesday, 4 May 2021, at 10:30, at IVA:s Konferenscenter, at Grev Turegatan 16, Stockholm. Registration for the meeting will commence at 10:00. NOTIFICATIONShareholders who wish to attend the meeting must:both be recorded in the share register maintained by Euroclear Sweden AB on the record date of Monday 26 April 2021; and  not later than on Wednesday 28 April 2021 have notified their attendance and possible advisors to the Company; either in writing via letter to Immunicum AB (publ), ”Annual General Meeting”, Östermalmstorg 5, SE-114 42 Stockholm, Sweden, or by e-mail to info@immunicum.com.The notification shall...

Press Release 31 March 2021 KALLELSE TILL ÅRSSTÄMMA I IMMUNICUM AB (PUBL) Aktieägarna i Immunicum AB (publ) (”Bolaget”), org.nr 556629-1786, kallas härmed till årsstämma tisdagen den 4 maj 2021 klockan 10:30 på IVA:s Konferenscenter på Grev Turegatan 16, Stockholm. Inregistrering till stämman påbörjas klockan 10:00. ANMÄLANAktieägare som önskar delta i stämman ska:dels vara införd i den av Euroclear Sweden AB förda aktieboken på avstämningsdagen som är måndagen den 26 april 2021, samt  dels senast onsdagen den 28 april 2021, ha anmält sitt deltagande och eventuellt biträde till Bolaget; antingen skriftligen till Immunicum AB (publ), ”Årsstämma”, Östermalmstorg 5, 114 42 Stockholm eller per e-post till info@immunicum.com.Vid anmälan ska uppges fullständigt namn, person- eller organisationsnummer, adress, telefonnummer dagtid samt,...

31 March 2021Announcement no. 5/2021 Alm. Brand A/S – Annual General Meeting on 26 April 2021 With reference to the information obligations for issuers of listed securities on Nasdaq Copenhagen A/S we attach the notice and the agenda of the annual general meeting and the complete proposals for the annual general meeting to be held on 26 April 2021. Contact Please direct any questions regarding this announcement to: Investors and equity analysts:                                  Senior Investor Relations OfficerMikael Bo LarsenMobile no. +45 5143 8002 Attachments

31. marts 2021Selskabsmeddelelse nr. 5/2021 Alm. Brand A/S – Ordinær generalforsamling den 26. april 2021 Med henvisning til oplysningsforpligtelserne for udstedere af børsnoterede værdipapirer på Nasdaq Copenhagen A/S fremsendes vedhæftet indkaldelse samt dagsorden og de fuldstændige forslag til den ordinære generalforsamling i Alm. Brand A/S den 26. april 2021. Kontakt Eventuelle henvendelser vedrørende denne selskabsmeddelelse bedes rettet til: Investorer og aktieanalytikere:                                 Senior Investor Relations OfficerMikael Bo Larsenmobil nr. 51 43 80 02 Vedhæftede filer

Un nouveau dispositif digital pour sublimer les vitrines des pharmacies, première mise en place à la pharmacie des 4 Temps à La Défense (92) Boulogne-Billancourt, le 31/03/2021 FUTURAMEDIA, acteur majeur du digital point de vente en France depuis 2004, annonce l’installation de dispositifs novateurs : 2 murs LED transparents de 6m². Mis en place à la pharmacie des 4 Temps à la Défense pour la régie publicitaire C-MEDIA, ce dispositif vient sublimer la vitrine grâce la technologie ‘LED ajouré’. Elle permet de diffuser des campagnes vidéos animées tout en laissant passer la lumière grâce à l’effet de transparence. La haute luminosité et le grand format de 6m² optimisent l’impact de la communication dynamique avec une parfaite intégration dans la vitrine de la pharmacie. FUTURAMEDIA dispose d’un service dédié à la R&D de solutions d’affichage...

The number of shares and votes in Active Biotech has changed as a result of allotment of performance shares under the company’s incentive program for the company’s employees (Plan 2020/2024). Today, the last trading day of the month, there are in total 217,971,720 shares and votes in Active Biotech. For further information, please contact:Hans Kolam, CFOTel: +46 (0)46 19 20 44E-mail: hans.kolam@activebiotech.com Active Biotech ABP.O. Box 724, SE-220 07 Lund, SwedenPhone +46 (0)46 19 20 00 About Active BiotechActive Biotech AB (publ) (Nasdaq Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant commercial potential. Following a...

Antalet aktier och röster i Active Biotech har förändrats till följd av tilldelning av prestationsaktier inom ramen för bolagets incitamentsprogram för anställda (Plan 2020/2024). Idag, den sista handelsdagen i månaden, finns totalt 217 971 720 aktier och röster i Active Biotech.           För ytterligare information, vänligen kontakta:Hans Kolam, CFOTel: 046 19 20 44E-mail: hans.kolam@activebiotech.com Active Biotech ABBox 724, 220 07 LundTfn 046-19 20 00 Om Active BiotechActive Biotech AB (publ) (NASDAQ Stockholm: ACTI) är ett bioteknikföretag som använder sin omfattande kompetensbas och projektportfölj för att utveckla unika immunmodulerande behandlingar för specialiserade onkologi- och immunologiska indikationer med stort medicinskt behov och betydande kommersiell potential. Efter beslut om en ny inriktning av forsknings- och utvecklingsverksamheten...